neoX Biotech
PrivateLast Round
Series A
Extension
Jul 8, 2021
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
neoX Biotech operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series A Extension round in July 2021.
neoX Biotech is a biotechnology company that integrates artificial intelligence, biophysics, and high-throughput experimentation to develop macromolecular and multi-specific drugs for immuno-oncology and other therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
neoX Biotech Comparables
Compare neoX Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Degron Therapeutics | 79% | |
| BigHat Biosciences | 79% | |
| Beyang Therapeutics Co., Ltd. | 78% |
For institutional investors. Book with your work email.
neoX Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 8, 2021 | ||||
| Series A | Feb 9, 2021 | ||||
| Pre Seed | Jul 6, 2020 | ||||
| Accelerator | Dec 1, 2019 | ||||
| Seed | Aug 24, 2018 | ||||
Seed | Jun 1, 2018 |
For institutional investors. Book with your work email.
neoX Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanjing Capital | Series A, Series A Extension, Pre Seed |
| MiraclePlus | Series A Extension |
| ZhenFund | Angel, Seed |
| LYFE Capital | Series A Extension |
| Sky9 Capital | Series A Extension, Series A |
| Genesis Capital | Series A Extension |
| Sequoia Capital | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 298% MoM, reaching 1.3K.
- Jul 8, 2021
Led by Genesis Capital and LYFE Capital.
For institutional investors. Book with your work email.
neoX Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about neoX Biotech's valuation, stock price, and market status.
Is neoX Biotech a public or private company?
neoX Biotech is a private company.
What is the current stock price of neoX Biotech?
neoX Biotech is a private company, so its shares have no public market price. Caplight tracks neoX Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is neoX Biotech worth (valuation)?
Valuation information for neoX Biotech is not publicly available.
Can I buy neoX Biotech stock?
neoX Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was neoX Biotech's last funding round?
neoX Biotech's most recent funding round was Series A Extension on July 8, 2021.
Who are the main investors in neoX Biotech?
Key investors in neoX Biotech include Yuanjing Capital, ZhenFund, LYFE Capital, Sky9 Capital, Genesis Capital.
Will neoX Biotech IPO soon?
No public IPO plans have been announced for neoX Biotech.
How can I track neoX Biotech secondary market activity?
Caplight tracks bids, offers, and trades in neoX Biotech's shares on secondary markets.